148 related articles for article (PubMed ID: 23918626)
1. Development of fragment-based n-FABS NMR screening applied to the membrane enzyme FAAH.
Lambruschini C; Veronesi M; Romeo E; Garau G; Bandiera T; Piomelli D; Scarpelli R; Dalvit C
Chembiochem; 2013 Sep; 14(13):1611-9. PubMed ID: 23918626
[TBL] [Abstract][Full Text] [Related]
2. Fluorine nuclear magnetic resonance-based assay in living mammalian cells.
Veronesi M; Giacomina F; Romeo E; Castellani B; Ottonello G; Lambruschini C; Garau G; Scarpelli R; Bandiera T; Piomelli D; Dalvit C
Anal Biochem; 2016 Feb; 495():52-9. PubMed ID: 26686030
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.
Wang Y; Ramirez F; Krishnamurthy G; Gilbert A; Kadakia N; Xu J; Kalgaonkar G; Ramarao MK; Edris W; Rogers KE; Jones PG
J Biomol Screen; 2006 Aug; 11(5):519-27. PubMed ID: 16760367
[TBL] [Abstract][Full Text] [Related]
4. Fluorine NMR functional screening: from purified enzymes to human intact living cells.
Dalvit C; Veronesi M; Vulpetti A
J Biomol NMR; 2020 Nov; 74(10-11):613-631. PubMed ID: 32347447
[TBL] [Abstract][Full Text] [Related]
5. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Holtfrerich A; Hanekamp W; Lehr M
Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
[TBL] [Abstract][Full Text] [Related]
6. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
[TBL] [Abstract][Full Text] [Related]
8. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
Labar G; Vliet FV; Wouters J; Lambert DM
Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
[TBL] [Abstract][Full Text] [Related]
9. A scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening.
Wang Y; Jones P
Methods Mol Biol; 2009; 572():247-59. PubMed ID: 20694697
[TBL] [Abstract][Full Text] [Related]
10. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase.
Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V
Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504
[TBL] [Abstract][Full Text] [Related]
12. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.
Lodola A; Rivara S; Mor M
Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320
[TBL] [Abstract][Full Text] [Related]
13. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Seierstad M; Breitenbucher JG
J Med Chem; 2008 Dec; 51(23):7327-43. PubMed ID: 18983142
[No Abstract] [Full Text] [Related]
14. A general NMR method for rapid, efficient, and reliable biochemical screening.
Dalvit C; Ardini E; Flocco M; Fogliatto GP; Mongelli N; Veronesi M
J Am Chem Soc; 2003 Nov; 125(47):14620-5. PubMed ID: 14624613
[TBL] [Abstract][Full Text] [Related]
15. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved (19) F NMR methodology.
Vulpetti A; Dalvit C
ChemMedChem; 2013 Dec; 8(12):2057-69. PubMed ID: 24127294
[TBL] [Abstract][Full Text] [Related]
16. Fluorine NMR-based screening on cell membrane extracts.
Veronesi M; Romeo E; Lambruschini C; Piomelli D; Bandiera T; Scarpelli R; Garau G; Dalvit C
ChemMedChem; 2014 Feb; 9(2):286-9. PubMed ID: 24339446
[TBL] [Abstract][Full Text] [Related]
17. Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.
Gustin DJ; Ma Z; Min X; Li Y; Hedberg C; Guimaraes C; Porter AC; Lindstrom M; Lester-Zeiner D; Xu G; Carlson TJ; Xiao S; Meleza C; Connors R; Wang Z; Kayser F
Bioorg Med Chem Lett; 2011 Apr; 21(8):2492-6. PubMed ID: 21392988
[TBL] [Abstract][Full Text] [Related]
18. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.
Jaiswal S; Tripathi RKP; Ayyannan SR
Biomed Pharmacother; 2018 Nov; 107():1611-1623. PubMed ID: 30257379
[TBL] [Abstract][Full Text] [Related]
19. Structure based design of novel irreversible FAAH inhibitors.
Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
[TBL] [Abstract][Full Text] [Related]
20. Reliable high-throughput functional screening with 3-FABS.
Dalvit C; Ardini E; Fogliatto GP; Mongelli N; Veronesi M
Drug Discov Today; 2004 Jul; 9(14):595-602. PubMed ID: 15239978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
